Veriteq Corp. (VTEQ) 0.0095 $VTEQ
Over 1,000 Women Worldwide Have Now Received Motiva Breast Implants with VeriTeQ's Q Inside Safety Technology
Business Wire - Tue Sep 16, 8:39AM CDT
VeriTeQ Corporation ("VeriTeQ"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 1,000 women worldwide have now received Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM). Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL" , featuring VeriTeQ's Q Inside Safety Technology(TM) can be safely and accurately identified from outside of the body in a physician's office.
VeriTeQ Corporation to Host Conference Call to Update Investors on Business and other Recent Events
Business Wire - Tue Aug 26, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it will host a conference call on Wednesday, September 3, 2014, at 10 a.m. ET, to update investors on the business and other recent events.
Adoption Increases for VeriTeQ's "Q Inside" Breast Implant Safety Technology
Business Wire - Thu Jul 17, 8:01AM CDT
--VeriTeQ's CEO Scott R. Silverman to present today at RedChip Companies' Global Online CEO Conference at 11 am ET
VeriTeQ Corporation Provides Business Update in New Interview With SmallCapVoice.com
GlobeNewswire - Wed Jul 16, 7:23AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with VeriTeQ Corporation ("VeriTeQ" or the "Company" (OTCQB:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, is now available. The interview with the Company's Chairman and CEO Scott R. Silverman can be heard at http://smallcapvoice.com/blog/7-15-14-smallca...-corp-vteq.
Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:35AM CDT
Hansen Medical one such stock considered to drop as it has witnessed a significant price decline and has seen negative earnings
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Thu Jun 19, 10:53AM CDT
RedChip Companies, Inc. ("RedChip" , an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"
TM) television program will feature three emerging growth companies on Fox Business nationwide on Thursday, June 19, 2014 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg U.K. Saturday, June 21, 2014 at 12:30 a.m. GMT; on Bloomberg Europe on Sunday, June 22, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday June 22, 2014 at 3:30 p.m. HKT.
VeriTeQ Appoints Former U.S. Ambassador Ned L. Siegel to its Board of Directors
Business Wire - Thu Jun 19, 10:38AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has appointed Ned L. Siegel, former U.S. Ambassador, to its Board of Directors, effective immediately. Ambassador Siegel will replace Michael Krawitz, the Company's Chief Legal and Financial Officer, as a director. Mr. Krawitz is stepping down from the Board to focus on his responsibilities as an executive of the Company and to enable the Company to increase its Board independence. Ambassador Siegel is a successful entrepreneur who brings more than 30 years of business and government experience to VeriTeQ, and will assist the Company with its strategic development and financing needs.
VeriTeQ Rebrands its "Q Inside SmartMarker" to Lead its Radiation Dosimetry Business; Q Inside Smart Marker is World's First Implantable Sensor Cleared by FDA to Measure Radiation Dose Directly at the Tumor Site
Business Wire - Thu Mar 27, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it is rebranding its Q Inside SmartMarker to lead its radiation dosimetry business. Q Inside SmartMarker (previously known as DVS SmartMarker(R)) is the only FDA- cleared implantable radio frequency ("RF" radiation sensor that provides localization of a tumor and measures radiation dose at the tumor site. VeriTeQ's radiation dosimetry products have six FDA clearances and CE approvals, and the Company has over 100 patents, patents pending, and exclusive licenses.
VeriTeQ Delivers Q Inside Safety Technology Readers to Establishment Labs
Business Wire - Wed Mar 12, 8:29AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has delivered Q Inside Safety Technology readers to its customer Establishment Labs, S.A. ("EL" . EL's Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology are the world's first externally identifiable breast implants, and are now available to patients in the EU.
New Breast Implant Recall in the EU Prompts Need for VeriTeQ's Device Traceability Technology
Business Wire - Mon Feb 24, 7:31AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, today commented on the latest breast implant recall in the European Union. Breast implants manufactured by French company Cereplas are being recalled by The National Security Agency of Medicines and Health Products ("ANSM" due to concerns regarding sterilization and equipment used in production of the implants.
VeriTeQ's Partner Establishment Labs Gets Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology
Close-Up Media - Thu Feb 20, 11:36PM CST
VeriTeQ Corp., a provider of implantable medical device identification and radiation dose measurement technologies, said that its breast implant partner Establishment Labs ("EL" has received additional CE Mark approvals for its Motiva Implant Matrix VelvetSurface PLUS with Q Inside Safety Technology and Motiva Implant Matrix SilkSurface PLUS with Q Inside Safety Technology.
VeriTeQ Partner Establishment Labs Receives Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology
Business Wire - Tue Feb 18, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that its breast implant partner Establishment Labs, S.A. ("EL" has received additional CE Mark approvals for its Motiva Implant Matrix(R) VelvetSurface PLUS with Q Inside Safety Technology and Motiva Implant Matrix(R) SilkSurface PLUS with Q Inside Safety Technology. EL's Motiva Implant Matrix product line with VeriTeQ's Q Inside Safety Technology offers the world's first externally identifiable breast implant.
Zack's Investment Research Initiates Coverage of VeriTeQ Corporation with an Outperform Rating
Business Wire - Wed Feb 12, 10:33AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that Zacks Investment Research ("Zacks" has initiated coverage of the Company with an outperform rating.
VeriTeQ Corporation Appoints Michael Krawitz Chief Legal and Financial Officer
Business Wire - Wed Feb 05, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that is has appointed Michael Krawitz its Chief Legal and Financial Officer. Mr. Krawitz is a skilled executive with extensive capital markets experience. The Company's previous Chief Financial Officer, Lorraine Breece, will remain with the Company in a different capacity.
VeriTeQ Corporation's Q Inside Safety Technology Launches in the European Union and United Kingdom
Business Wire - Tue Feb 04, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today the launch of its Q Inside Safety Technology in the European Union and United Kingdom, where women have already received breast implants from VeriTeQ's partner, Establishment Labs, S.A. ("EL" , which offers its Motiva Implant Matrix Ergonomix(TM) with VeriTeQ's Q Inside Safety Technology.
VeriTeQ to be Featured at RedChip Emerging Growth Showcase on January 22
Business Wire - Tue Jan 21, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it will be featured at the RedChip Emerging Growth Showcase on Wednesday, January 22, 2014. VeriTeQ's presentation will air at 12:00 pm ET at http://redchip.com/visibility/investor.asp?sy...confpage31.
VeriTeQ Delivers an Additional 6,000 Q Inside Safety Transponders to Establishment Labs in January
Business Wire - Tue Jan 14, 7:29AM CST
--First customers expected to take delivery of Motiva Implant Matrix Ergonomix with Q Inside Safety Technology during the first quarter
VeriTeQ Endorses England's Decision to Launch Breast Implant Registry to Track Procedures and Devices
Business Wire - Wed Jan 08, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that a new breast implant registry will be launched in England beginning early this year to track breast implant procedures performed in the country. Health ministers in Wales, Scotland and Northern Ireland will also be encouraged to join the register.
VeriTeQ Corporation to Be Featured in Interview on Fox Business and Bloomberg Television
Business Wire - Mon Jan 06, 7:29AM CST
VeriTeQ Corporation ("VeriTeQ" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it is featured in an interview on "The RedChip Money Report: Small Stocks Big Money", which will be broadcast on Fox Business and Bloomberg television networks. The interview can currently be viewed online at http://youtu.be/F-UC5lBp2Ns.
Over 1,000 Women Worldwide Have Now Received Motiva Breast Implants with VeriTeQ's Q Inside Safety Technology
Business Wire - Tue Sep 16, 8:39AM CDT
VeriTeQ Corporation ("VeriTeQ"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 1,000 women worldwide have now received Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM). Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL" , featuring VeriTeQ's Q Inside Safety Technology(TM) can be safely and accurately identified from outside of the body in a physician's office. VeriTeQ Corporation to Host Conference Call to Update Investors on Business and other Recent Events
Business Wire - Tue Aug 26, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it will host a conference call on Wednesday, September 3, 2014, at 10 a.m. ET, to update investors on the business and other recent events. Adoption Increases for VeriTeQ's "Q Inside" Breast Implant Safety Technology
Business Wire - Thu Jul 17, 8:01AM CDT
--VeriTeQ's CEO Scott R. Silverman to present today at RedChip Companies' Global Online CEO Conference at 11 am ET
VeriTeQ Corporation Provides Business Update in New Interview With SmallCapVoice.com
GlobeNewswire - Wed Jul 16, 7:23AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with VeriTeQ Corporation ("VeriTeQ" or the "Company"
(OTCQB:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, is now available. The interview with the Company's Chairman and CEO Scott R. Silverman can be heard at http://smallcapvoice.com/blog/7-15-14-smallca...-corp-vteq. Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:35AM CDT
Hansen Medical one such stock considered to drop as it has witnessed a significant price decline and has seen negative earnings
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Thu Jun 19, 10:53AM CDT
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" TM) television program will feature three emerging growth companies on Fox Business nationwide on Thursday, June 19, 2014 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg U.K. Saturday, June 21, 2014 at 12:30 a.m. GMT; on Bloomberg Europe on Sunday, June 22, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday June 22, 2014 at 3:30 p.m. HKT. VeriTeQ Appoints Former U.S. Ambassador Ned L. Siegel to its Board of Directors
Business Wire - Thu Jun 19, 10:38AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has appointed Ned L. Siegel, former U.S. Ambassador, to its Board of Directors, effective immediately. Ambassador Siegel will replace Michael Krawitz, the Company's Chief Legal and Financial Officer, as a director. Mr. Krawitz is stepping down from the Board to focus on his responsibilities as an executive of the Company and to enable the Company to increase its Board independence. Ambassador Siegel is a successful entrepreneur who brings more than 30 years of business and government experience to VeriTeQ, and will assist the Company with its strategic development and financing needs. VeriTeQ Rebrands its "Q Inside SmartMarker" to Lead its Radiation Dosimetry Business; Q Inside Smart Marker is World's First Implantable Sensor Cleared by FDA to Measure Radiation Dose Directly at the Tumor Site
Business Wire - Thu Mar 27, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it is rebranding its Q Inside SmartMarker to lead its radiation dosimetry business. Q Inside SmartMarker (previously known as DVS SmartMarker(R)) is the only FDA- cleared implantable radio frequency ("RF" radiation sensor that provides localization of a tumor and measures radiation dose at the tumor site. VeriTeQ's radiation dosimetry products have six FDA clearances and CE approvals, and the Company has over 100 patents, patents pending, and exclusive licenses. VeriTeQ Delivers Q Inside Safety Technology Readers to Establishment Labs
Business Wire - Wed Mar 12, 8:29AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has delivered Q Inside Safety Technology readers to its customer Establishment Labs, S.A. ("EL" . EL's Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology are the world's first externally identifiable breast implants, and are now available to patients in the EU. New Breast Implant Recall in the EU Prompts Need for VeriTeQ's Device Traceability Technology
Business Wire - Mon Feb 24, 7:31AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, today commented on the latest breast implant recall in the European Union. Breast implants manufactured by French company Cereplas are being recalled by The National Security Agency of Medicines and Health Products ("ANSM" due to concerns regarding sterilization and equipment used in production of the implants. VeriTeQ's Partner Establishment Labs Gets Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology
Close-Up Media - Thu Feb 20, 11:36PM CST
VeriTeQ Corp., a provider of implantable medical device identification and radiation dose measurement technologies, said that its breast implant partner Establishment Labs ("EL"
has received additional CE Mark approvals for its Motiva Implant Matrix VelvetSurface PLUS with Q Inside Safety Technology and Motiva Implant Matrix SilkSurface PLUS with Q Inside Safety Technology. VeriTeQ Partner Establishment Labs Receives Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology
Business Wire - Tue Feb 18, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that its breast implant partner Establishment Labs, S.A. ("EL" has received additional CE Mark approvals for its Motiva Implant Matrix(R) VelvetSurface PLUS with Q Inside Safety Technology and Motiva Implant Matrix(R) SilkSurface PLUS with Q Inside Safety Technology. EL's Motiva Implant Matrix product line with VeriTeQ's Q Inside Safety Technology offers the world's first externally identifiable breast implant. Zack's Investment Research Initiates Coverage of VeriTeQ Corporation with an Outperform Rating
Business Wire - Wed Feb 12, 10:33AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that Zacks Investment Research ("Zacks" has initiated coverage of the Company with an outperform rating. VeriTeQ Corporation Appoints Michael Krawitz Chief Legal and Financial Officer
Business Wire - Wed Feb 05, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that is has appointed Michael Krawitz its Chief Legal and Financial Officer. Mr. Krawitz is a skilled executive with extensive capital markets experience. The Company's previous Chief Financial Officer, Lorraine Breece, will remain with the Company in a different capacity. VeriTeQ Corporation's Q Inside Safety Technology Launches in the European Union and United Kingdom
Business Wire - Tue Feb 04, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today the launch of its Q Inside Safety Technology in the European Union and United Kingdom, where women have already received breast implants from VeriTeQ's partner, Establishment Labs, S.A. ("EL" , which offers its Motiva Implant Matrix Ergonomix(TM) with VeriTeQ's Q Inside Safety Technology. VeriTeQ to be Featured at RedChip Emerging Growth Showcase on January 22
Business Wire - Tue Jan 21, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it will be featured at the RedChip Emerging Growth Showcase on Wednesday, January 22, 2014. VeriTeQ's presentation will air at 12:00 pm ET at http://redchip.com/visibility/investor.asp?sy...confpage31. VeriTeQ Delivers an Additional 6,000 Q Inside Safety Transponders to Establishment Labs in January
Business Wire - Tue Jan 14, 7:29AM CST
--First customers expected to take delivery of Motiva Implant Matrix Ergonomix with Q Inside Safety Technology during the first quarter
VeriTeQ Endorses England's Decision to Launch Breast Implant Registry to Track Procedures and Devices
Business Wire - Wed Jan 08, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ"
(OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that a new breast implant registry will be launched in England beginning early this year to track breast implant procedures performed in the country. Health ministers in Wales, Scotland and Northern Ireland will also be encouraged to join the register. VeriTeQ Corporation to Be Featured in Interview on Fox Business and Bloomberg Television
Business Wire - Mon Jan 06, 7:29AM CST
VeriTeQ Corporation ("VeriTeQ"
(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it is featured in an interview on "The RedChip Money Report: Small Stocks Big Money", which will be broadcast on Fox Business and Bloomberg television networks. The interview can currently be viewed online at http://youtu.be/F-UC5lBp2Ns. 
